Cargando…

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis

F-box protein 5 (FBXO5), an essential subunit of the ubiquitin protein ligase complex, is increasingly recognized to exhibit important biological effects in regulating tumor occurrence and progression. The present research was intended to systematically investigate the latent roles of FBXO5 in progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Wang, Xiaojuan, Pan, Lili, Han, Bing, He, Zhiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203914/ https://www.ncbi.nlm.nih.gov/pubmed/35720327 http://dx.doi.org/10.3389/fimmu.2022.901784

Ejemplares similares

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

Immunological role and prognostic value of the SKA family in pan-cancer analysis
por: Li, Zhengtian, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis
por: Liang, Xiao, et al.
Publicado: (2022)

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023)

A comprehensive pan-cancer analysis of CDH5 in immunological response
por: Li, Yuantao, et al.
Publicado: (2023)

Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer
por: Liu, Yaqian, et al.
Publicado: (2021)

Prognostic value and immunological role of PTPN21 in pan-cancer analysis
por: Yang, YanE, et al.
Publicado: (2023)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
por: Zhong, Hongguang, et al.
Publicado: (2023)

Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer
por: Yang, Runyu, et al.
Publicado: (2023)

A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma
por: Zhang, Dandan, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design
por: Zhang, Si-Han, et al.
Publicado: (2023)

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma
por: Li, Chaolin, et al.
Publicado: (2023)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018)

Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker
por: Jin, Haoer, et al.
Publicado: (2022)

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer
por: Gao, Zhi-Jie, et al.
Publicado: (2023)

Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker
por: Xie, Mingchen, et al.
Publicado: (2023)

Immunologic Gene Sets Reveal Features of the Tumor Immune Microenvironment and Predict Prognosis and Immunotherapy Response: A Pan-Cancer Analysis
por: Pan, Hongda, et al.
Publicado: (2022)

FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
por: Zhong, Anyuan, et al.
Publicado: (2021)

Prognostic and Immunological Roles of MMP-9 in Pan-Cancer
por: Zeng, Yudan, et al.
Publicado: (2022)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

Prognostic and immunological role of Fam20C in pan-cancer
por: Liu, Xinpeng, et al.
Publicado: (2021)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Identification of ISCA1 as novel immunological and prognostic biomarker for bladder cancer
por: Zhou, Renlong, et al.
Publicado: (2022)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q26uu7e127f24etqa7frcjrb33